REQUEST A DEMO
Total
USD $0.00
Search more companies

Endosurgery Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Endosurgery Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Endosurgery Sdn. Bhd. is based in Malaysia. The head office is in Petaling Jaya. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on May 15, 2012. From the latest financial highlights, Endosurgery Sdn. Bhd. reported a net sales revenue increase of 35.24% in 2023. Over the same period, its total assets grew by 29.81%. In 2023, Endosurgery Sdn. Bhd.’s net profit margin increased by 12.85%.

Headquarters
A-09-06 Tower A Menara Prima,Jalan Pju 1/39, Dataran Prima,
Petaling Jaya; Selangor; Postal Code: 47301

Contact Details: Purchase the Endosurgery Sdn. Bhd. report to view the information.

Website: http://endosurgery.com.my

Basic Information
Outstanding Shares:
Purchase the Endosurgery Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Endosurgery Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Endosurgery Sdn. Bhd. report to view the information.
Incorporation Date:
May 15, 2012
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Endosurgery Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
35.24%
Total operating revenue
35.24%
Operating profit (EBIT)
319.54%
EBITDA
287.41%
Net Profit (Loss) for the Period
355.7%
Total assets
29.81%
Total equity
56.49%
Operating Profit Margin (ROS)
16%
Net Profit Margin
12.85%
Return on Equity (ROE)
23.7%
Debt to Equity Ratio
-17.64%
Quick Ratio
0.62%
Cash Ratio
0.34%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?